Home/Filings/4/0000899243-20-032670
4//SEC Filing

Epstein David M. 4

Accession 0000899243-20-032670

CIK 0001701541other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 4:17 PM ET

Size

16.0 KB

Accession

0000899243-20-032670

Insider Transaction Report

Form 4
Period: 2020-12-01
Epstein David M.
DirectorSee Remarks
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2020-12-013,000235,616 total
    Exercise: $6.42Exp: 2029-08-13Common Stock (3,000 underlying)
  • Sale

    Common Stock

    2020-12-01$32.64/sh10,923$356,553704,000 total
  • Exercise/Conversion

    Common Stock

    2020-12-01$6.42/sh+3,000$19,260714,923 total
  • Sale

    Common Stock

    2020-12-01$33.45/sh1,077$36,021702,923 total
Holdings
  • Common Stock

    (indirect: See footnote)
    104,449
  • Common Stock

    (indirect: See footnote)
    23,090
  • Common Stock

    (indirect: See footnote)
    104,449
  • Common Stock

    (indirect: See footnote)
    16,579
  • Common Stock

    (indirect: See footnote)
    16,579
Footnotes (9)
  • [F1]Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.19 to $33.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.26 to $33.56 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  • [F4]Shares held by wife.
  • [F5]Shares held by David M. Epstein 2019 Trust For Elle. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Elle and may be deemed to beneficially own these securities.
  • [F6]Shares held by David M. Epstein 2019 Trust For Zoe. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Zoe and may be deemed to beneficially own these securities.
  • [F7]Shares held by David M. Epstein 2019 Trust For Robert. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Robert and may be deemed to beneficially own these securities.
  • [F8]Shares held by David M. Epstein 2019 Trust For Shelley. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Shelley and may be deemed to beneficially own these securities.
  • [F9]25% of the shares subject to this option vested and became exercisable on August 14, 2020, with the remainder vesting in 36 equal monthly installments thereafter.

Issuer

Black Diamond Therapeutics, Inc.

CIK 0001701541

Entity typeother

Related Parties

1
  • filerCIK 0001488668

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:17 PM ET
Size
16.0 KB